Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GWP42004 as Add-on to Metformin in Type 2 Diabetes
NCT02053272Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Feb 2014
- Primary completion
- Feb 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tetrahydrocannabivarin in type 2 diabetes mellitus (T2DM), sponsored by Jazz Pharmaceuticals plc. Started Feb 2014; status: completed.
02
Drugs
tetrahydrocannabivarin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02053272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053272.